Show simple item record

Cost of services provided by the N ational B reast and C ervical Cancer E arly D etection P rogram

dc.contributor.authorEkwueme, Donatus U.en_US
dc.contributor.authorSubramanian, Sujhaen_US
dc.contributor.authorTrogdon, Justin G.en_US
dc.contributor.authorMiller, Jacqueline W.en_US
dc.contributor.authorRoyalty, Janet E.en_US
dc.contributor.authorLi, Chunyuen_US
dc.contributor.authorGuy, Gery P.en_US
dc.contributor.authorCrouse, Wesleyen_US
dc.contributor.authorThompson, Hopeen_US
dc.contributor.authorGardner, James G.en_US
dc.date.accessioned2014-08-06T16:49:52Z
dc.date.availableWITHHELD_13_MONTHSen_US
dc.date.available2014-08-06T16:49:52Z
dc.date.issued2014-08-15en_US
dc.identifier.citationEkwueme, Donatus U.; Subramanian, Sujha; Trogdon, Justin G.; Miller, Jacqueline W.; Royalty, Janet E.; Li, Chunyu; Guy, Gery P.; Crouse, Wesley; Thompson, Hope; Gardner, James G. (2014). "Cost of services provided by the N ational B reast and C ervical Cancer E arly D etection P rogram." Cancer 120(S16): 2604-2611.en_US
dc.identifier.issn0008-543Xen_US
dc.identifier.issn1097-0142en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/108058
dc.publisherOxford University Pressen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherCervical Cancer Screeningen_US
dc.subject.otherProgram Evaluationen_US
dc.subject.otherEconomic Costen_US
dc.subject.otherCost Analysisen_US
dc.subject.otherNBCCEDPen_US
dc.subject.otherBreast Cancer Screeningen_US
dc.titleCost of services provided by the N ational B reast and C ervical Cancer E arly D etection P rogramen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/108058/1/cncr28816.pdf
dc.identifier.doi10.1002/cncr.28816en_US
dc.identifier.sourceCanceren_US
dc.identifier.citedreferenceLegler J, Meissner HI, Coyne C, Breen N, Chollette V, Rimer BK. The effectiveness of interventions to promote mammography among women with historically lower rates of screening. Cancer Epidemiol Biomarkers Prev. 2002; 11: 59 ‐ 71.en_US
dc.identifier.citedreferenceHalpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol 2008; 9: 222 ‐ 231.en_US
dc.identifier.citedreferenceEkwueme DU, Gardner JG, Subramanian S, Tangka FK, Bapat B, Richardson LC. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004. Cancer 2008; 112: 626 ‐ 635.en_US
dc.identifier.citedreferenceLee NC, Wong FL, Jamison PM, et al. Implementation of the National Breast and Cervical Cancer Early Detection Program: The beginning. Cancer. 2014; 120 ( 16 Suppl. ): 2540 ‐ 2548.en_US
dc.identifier.citedreferenceSubramanian S, Ekwueme DU, Gardner JG, Trogdon J. Developing and testing a cost‐assessment tool for cancer screening programs. Am J Prev Med. 2009; 37: 242 ‐ 247.en_US
dc.identifier.citedreferenceSchousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost‐effectiveness. Ann Intern Med. 2011; 155: 10 ‐ 20.en_US
dc.identifier.citedreferenceMandelblatt JS, Schechter CB, Yabroff KR, et al. Toward optimal screening strategies for older women: costs, benefits, and harms of breast cancer screening by age, biology, and health status. J Gen Intern Med. 2005; 20: 487 ‐ 496.en_US
dc.identifier.citedreferencePoplack SP, Carney PA, Weiss JE, Titus‐Ernstoff L, Goodrich ME, Tosteson AN. Screening mammography: costs and use of screening‐related services. Radiology. 2005; 234: 79 ‐ 85.en_US
dc.identifier.citedreferenceO'Malley AS, Lawrence W, Liang W, et al. Feasibility of mobile cancer screening and prevention. J Health Care Poor Underserved. 2002; 13: 298 ‐ 319.en_US
dc.identifier.citedreferenceMcCrory DC, Matchar DB, Bastian L, et al. Evaluation of cervical cytology. Evid Rep Technol Assess (Summ). 1999; 5: 1 ‐ 6.en_US
dc.identifier.citedreferenceKulasingam SL, Myers ER. Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. JAMA. 2003; 290: 781 ‐ 789.en_US
dc.identifier.citedreferenceSchabert VF, Ye X, Insinga RP, Singhal PK, Riedel AA. Five‐year routine cervical cancer screening rates and intervals in a US health plan. Curr Med Res Opin. 2008; 24: 2429 ‐ 2435.en_US
dc.identifier.citedreferenceMelnikow J, Kulasingam S, Slee C, et al. Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost‐effectiveness. Obstet Gynecol. 2010; 116: 1158 ‐ 1170.en_US
dc.identifier.citedreferenceGoldie SJ, Kim JJ, Wright TC. Cost‐effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more. Obstet Gynecol. 2004; 103: 619 ‐ 631.en_US
dc.identifier.citedreferenceGold MR, Siegel JE, Russell L.B, Weinstein MC. Cost‐Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.en_US
dc.identifier.citedreferenceYabroff RK, Warren JL, Brown ML. Costs of cancer care in the USA: a descriptive review. Nat Clin Pract Oncol. 2007; 4: 643 ‐ 656.en_US
dc.identifier.citedreferenceGreenberg D, Earle C, Fang CH, Eldar‐Lissai A, Neumann PJ. When is cancer care cost‐effective? A systematic overview of cost‐utility analyses in oncology. J Natl Cancer Inst. 2010; 102: 82 ‐ 88.en_US
dc.identifier.citedreferenceMarcus AC, Crane LA. A review of cervical cancer screening intervention research: implications for public health programs and future research. Prev Med. 1998; 27: 13 ‐ 31.en_US
dc.identifier.citedreferenceMeissner HI, Breen N, Coyne C, Legler JM, Green D, Edwards BK. Breast and cervical cancer screening interventions: an assessment of the literature. Cancer Epidemiol Biomarkers Prev. 1998; 7: 951 ‐ 961.en_US
dc.identifier.citedreferenceStone EG, Morton SC, Hulscher ME, et al. Interventions that increase use of adult immunization and cancer screening services: a meta‐analysis. Ann Intern Med. 2002; 136: 641 ‐ 651.en_US
dc.identifier.citedreferenceBreen N, Wagener DK, Brown ML, Davis WW, Ballard‐Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst. 2001; 93: 1704 ‐ 1713.en_US
dc.identifier.citedreferenceMandelblatt JS, Gold K, O'Malley AS, et al. Breast and cervix cancer screening among multiethnic women: role of age, health, and source of care. Prev Med. 1998; 28: 418 ‐ 425.en_US
dc.identifier.citedreferenceBaron RC, Melillo S, Rimer BK, Coates RJ, Kerner J, Habarta N. Task Force on Community Preventive Services. Intervention to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers: a systematic review of provider reminders. Am J Prev Med, 2010; 38: 110 ‐ 117.en_US
dc.identifier.citedreferenceBickell NA, Wang JJ, Oluwole S, et al. Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol. 2006; 24: 1357 ‐ 1362.en_US
dc.identifier.citedreferencePsooy BJ, Schreuer D, Borgaonkar J, Caines JS. Patient navigation: improving timeliness in the diagnosis of breast abnormalities. Can Assoc Radiol J. 2004; 55: 145 ‐ 150.en_US
dc.identifier.citedreferenceBattaglia TA, Roloff K, Posner MA, Freund KM. Improving follow‐up to abnormal breast cancer screening in an urban population. A patient navigation intervention. Cancer. 2007; 109 ( 2 Suppl ): 359 ‐ 367.en_US
dc.identifier.citedreferenceRamsey SD, Whitley E, Mears VW, et al. Evaluating the cost‐effectiveness of cancer patient navigation programs: conceptual and practical issues. Cancer. 2009; 115: 5394 ‐ 403.en_US
dc.identifier.citedreferencePeipins LA, Graham S, Young R, et al. Time and distance barriers to mammography facilities in the Atlanta metropolitan area. J Community Health. 2011; 36: 675 ‐ 83.en_US
dc.identifier.citedreferenceGwyn K, Bondy ML, Cohen DS, et al. Racial differences in diagnosis, treatment, and clinical delays in a population‐based study of patients with newly diagnosed breast carcinoma. Cancer. 2004; 100: 1595 ‐ 1604.en_US
dc.identifier.citedreferenceEkwueme DU, Hall IJ, Richardson LC, Gardner JG, Royalty J, Thompson TD. Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program. Cancer. 2008; 113: 592 ‐ 601.en_US
dc.identifier.citedreferenceHoerger TJ, Ekwueme DU, Miller JW, et al. Estimated effects of the National Breast and Cervical Cancer Early Detection Program on breast cancer mortality. Am J Prev Med. 2011; 40: 397 ‐ 3404.en_US
dc.identifier.citedreferenceU.S. Preventive Services Task Force. Prevention and care management. Available at http://www.ahrq.gov/clinic/prevenix.htm.en_US
dc.identifier.citedreferenceNelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151: 727 ‐ 37.en_US
dc.identifier.citedreferenceU.S. Preventive Services Task Force. Prevention and care management. Available at http://www.uspreventiveservicestaskforce.org/uspstf/uspscerv.htm. Accessed on September 25, 2013.en_US
dc.identifier.citedreferenceKohler BA, Ward E, McCarthy BJ, et al. Annual report to the nation on the status of cancer, 1975‐2007, featuring tumors of the brain and other nervous system. Natl Cancer Inst 2011; 103: 714 ‐ 736.en_US
dc.identifier.citedreferenceHealthy People 2010 Final Review. Available from URL: www.cdc.gov/nchs/healthy_people/hp2010/hp2010_final_review.htm. Accessed on September 25, 2013.en_US
dc.identifier.citedreferenceSabatino SA, Coates RJ, Uhler RJ, Breen N, Tangka F, Shaw KM. Disparities in mammography use among US women aged 40‐64 years, by race, ethnicity, income, and health insurance status, 1993 and 2005. Med Care 2008; 46(7): 692 ‐ 700.en_US
dc.identifier.citedreferenceWard E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 2008; 58: 9 ‐ 31.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.